Market›Health Care›Biotechnology›Biotechnology
CAMP4 THERAPEUTICS C

CAMP

$4.44Oct 11, 2024 – Apr 24, 2026
Health CareBiotechnology$239M
MVM
+$5.2M
TD Variance
1.400

Every news event mapped to its market reaction — 38 events, 19 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2026-03-07+48.5%newsSeeking AlphaCamp4 Therapeutics: Strong Cash Runway As CMP-002 Moves Toward Human Trials
2026-03-07+48.5%newsSeeking AlphaCamp4 Therapeutics: Strong Cash Runway As CMP-002 Moves Toward Human Trials (NASDAQ:CAMP) - Seeking Alpha
2026-03-06+37.2%newsGlobeNewswireCAMP4 to Participate in Upcoming Investor Conferences
2025-08-15+20.3%earningsSeeking AlphaCamp4 Therapeutics GAAP EPS of -$0.62 beats by $0.06, revenue of $1.5M beats by $1.2M
2025-05-13-12.2%earningsStock TitanCAMP4 Clinical Trials Hit Major Milestone: Q1 Earnings Show Strong Pipeline Progress in Rare Disease Treatment - Stock Titan
2025-11-07-8.2%earningsSeeking AlphaCamp4 Therapeutics reports Q3 results
2025-01-13-8.2%executiveStock TitanCAMP4 Therapeutics CEO to Present Corporate Update at J.P. Morgan Healthcare Conference - Stock Titan
2025-03-28-8.1%earningsSeeking AlphaCamp4 Therapeutics GAAP EPS of -$11.04
2025-04-25-8.0%newsStock TitanKPTI Stock Price, News & Analysis - Stock Titan
2025-04-25-8.0%newsStock TitanGANX Stock Price, News & Analysis - Stock Titan
2024-11-05+7.0%newsSeeking AlphaCamp4 gains after earning bullish views on Street
2026-03-18-5.4%newsMotley FoolBiotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit
2026-03-18-5.4%newsMotley FoolBiotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit
2026-01-15-5.3%newsSeeking AlphaCamp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
2026-03-05+4.8%newsGlobeNewswireCAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
2026-03-05+4.8%earningsSeeking AlphaCamp4 Therapeutics GAAP EPS of -$2.65 misses by $0.77, revenue of $3.5M in-line
2026-03-05+4.8%newsGlobeNewswireCAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights - GlobeNewswire
2026-04-23-3.0%newsStock TitanCAMP4 (CAMP) details director votes, auditor ratification and equity plan - Stock Titan
2026-02-20+1.9%newsGlobeNewswireCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-04-13-1.5%newsMarketBeatCAMP4 Therapeutics Unveils Gene-Upregulation ASO Platform, Targets SYNGAP1 Clinic Entry in 2H
2026-03-12-1.3%newsTipRanksBiotech Alert: Searches spiking for these stocks today
2026-03-24+1.1%executiveGlobeNewswireCAMP4 Appoints Michael MacLean to its Board of Directors
2026-03-24+1.1%executiveStock TitanBiotech CAMP4 taps veteran CFO as it pushes SYNGAP1 drug to trial - Stock Titan
2026-03-24+1.1%newsStock TitanNew CAMP4 (NASDAQ: CAMP) director MacLean joins, receives option grant - Stock Titan
2026-04-17-0.8%newsGlobeNewswireCAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-04-17-0.8%newsStock TitanThree new CAMP4 hires get stock options at $4.59 a share - Stock Titan
2026-04-17-0.8%newsYahoo FinanceCAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
2026-04-17-0.8%newsmarketscreener.comCamp4 therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - marketscreener.com
2024-11-21+0.7%earningsSeeking AlphaCamp4 Therapeutics GAAP EPS of -$24.19
2026-04-03-0.0%newsStock TitanCamp4 Therapeutics (CAMP) CMO receives 215,000 stock options grant - Stock Titan
2026-04-03-0.0%executiveStock TitanCamp4 Therapeutics (CAMP) grants 170,000 stock options to Chief Scientific Officer - Stock Titan
2026-04-03-0.0%executiveStock TitanCamp4 Therapeutics (CAMP) CFO receives 215,000 stock options grant - Stock Titan
2026-04-03-0.0%newsStock TitanCamp4 Therapeutics (CAMP) director awarded 56,000 stock options at $4.46 strike - Stock Titan
2026-04-03-0.0%executiveStock TitanCamp4 Therapeutics Corp (CAMP) CEO granted 580,000 stock options at $4.46 - Stock Titan
2026-04-03-0.0%newsStock TitanCamp4 Therapeutics (CAMP) director Michael MacLean files initial Form 3 - Stock Titan
2026-04-26—newsMSN3 Healthcare Companies Insiders Are Buying - MSN
2024-10-11—newsSeeking AlphaCAMP4 stock edges up 2% following $75M IPO
2024-10-11—newsSeeking AlphaCAMP4 Therapeutics prices $75M IPO at $11 per share
tickerdossier.comtickerdossier.substack.com